Neuralink is expanding its clinical trials to the UK, aiming to test its brain implants on patients with severe paralysis. The study will assess how effectively the chips enable users to control devices using only their thoughts. This marks Neuralink's first foray into the UK market. The company hopes to demonstrate the potential of its technology to restore independence for individuals with limited mobility.